Skip to content
This project aims to monitor the impact of the vaccine Prevenar13 on otitis media among Indigenous Australian children in the Northern Territory and Western Australia in 2013.
Currently Prevenar13 immunises against seven different types of bacteria which cause otitis media, but there are other types that are not immunised against, and the prevalence of these is increasing.
The objectives of this project are to:
This project is part of ongoing monitoring of Prevenar13 efficacy and is an initiative of the Menzies School of Health Research and Pfizer.
Abstract adapted from Menzies School of Health Research
Menzies School of Health Research
John Matthews Building
Royal Darwin Hospital Campus
PO Box 41096
Casuarina NT 0811
Ph: (08) 8922 8196
Fax: (08) 8927 5187